We believe we can release the capacity of mRNA for easier, safer and more affordable treatment. We have worked on the simple, one-step mRNA Drug Discovery Platform, from mRNA synthesis, early discovery for new targets, and a rapid expanding pipeline. We focus on the mRNA-based vaccines and therapies of severe diseases. Powered by the cooperative labs, in-house mRNA manufacture capabilities and future new target discoveries, we aim to find the path to the cutting-edge spectrum of mRNA therapy.